Arcturus Therapeutics Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Arcturus Therapeutics Ltd. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $6.95 per share as of 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2019-05-13
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $6.95.
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $7.41.
- 2018-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $7.64.
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $8.70.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2019-03-31 | $6.95 10-Q · filed 2019-05-13 |
| 2018-12-31 | $7.41 10-Q · filed 2019-05-13 |
| 2018-09-30 | $7.64 6-K · filed 2018-11-07 |
| 2017-12-31 | $8.70 10-K · filed 2019-03-18 |
| 2016-12-31 | $2.15 20-F · filed 2018-05-14 |